Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Cognito’s non-invasive medical device demonstrates durable effects on activities of daily living through OVERTURE open-label extension study.

Author:Kern, Ralph   Kuang, Colin   Hajos, Mihaly   Konisky, Alex   Boasso, Alyssa   Hempel, Evan   Vaughan, Brent   Seshagiri, Chandran   Malchano, Zach   Hendrix, Suzanne   Saikali, Khalil   Massey, Joseph   Arjunji, Ramesh   

Session Name:N2: Neuroscience in the Clinic: Neuromodulation: From Bench to Bedside  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:N2.002  

Author Institution:Cognito Therapeutics, Cambridge, MA  Cognito Therapeutics, Canbridge, MA  Cognito Therapeutics, Somerville, MA  Pentara Corporation, Salt Lake City, UT  SSI Strategy, Parsippany, NJ  

Early-Onset Parkinson’s Disease in Women: A comparison of Hormonal Exposure with Late-Onset Parkinson’s Disease and Unaffected Controls

Author:Patane, Gaia   Mullan, Aidan   Piat, Capucine   Turcano, Pierpaolo   Savica, Rodolfo   

Session Name:N3: Neuroscience in the Clinic: Menopause: Why Does It Matter for Neurologic Disease?  

Topic:Movement Disorders  

Program Number:N3.001  

Author Institution:Mayo Clinic , Catania, Italy  Mayo Clinic, Rochester, MN  Mayo Clinic , Rochester, MN  Mayo Clinic, Jacksonville, FL  

Prevalence of Female-Specific Risk Factors in Women with Ischemic and Hemorrhagic Stroke

Author:Rice, Victoria   Helms, Katy   Lingam, Sneha   Armstrong, Sierra   Guzynski, Mia   Guzik, Amy   Bushnell, Cheryl   

Session Name:N3: Neuroscience in the Clinic: Menopause: Why Does It Matter for Neurologic Disease?  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:N3.002  

Author Institution:Wake Forest Baptist Medical Center, Winston Salem, NC  Wake Forest Baptist Medical Center, Winston-Salem, NC  Wake Forest University Baptist Medical Center, Winston Salem, NC  Wake Forest School Of Medicine, Winston Salem, NC  

Eligibility for the Donanemab Trial in a Population-Based Study of Cognitive Aging

Author:Jones, Katherine   Aakre, Jeremiah   Castillo, Anna   Ramanan, Vijay   Kremers, Walter   Jack, Clifford   Vemuri, Prashanthi   Lowe, Val   Knopman, David   Petersen, Ronald   Vassilaki, Maria   Graff-Radford, Jonathan   

Session Name:N4: Neuroscience in the Clinic: Alzheimer's Disease Biomarker Testing and Amyloid Monoclonals in Clinical Practice  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:N4.001  

Author Institution:Mayo Clinic, Rochester, MN  

Neuroinflammation Co-localizes Highly with Tau in Mild Cognitive Impairment from Early Onset Alzheimer’s Disease

Author:Appleton, Johanna   Funk, Quentin   Zanotti Fregonara, Paolo   Yu, Meixiang   Faridar, Alirexa   Nakawah, Mohammad   Carrillo, Maria   Dickerson, Bradford   Rabinovici, Gil   Apostolova, Liana   Masdeu, Joseph   Pascual, Belen   

Session Name:N4: Neuroscience in the Clinic: Alzheimer's Disease Biomarker Testing and Amyloid Monoclonals in Clinical Practice  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:N4.002  

Author Institution:Houston Methodist, Houston, TX  Molecular Imaging Branch, National Institute of Mental Health, Houston, TX  Methodist Neurological Institute, Houston, TX  Houston Methodist Hospital, Houston, TX  Alzheimer's Association, Chicago, IL  Massachusetts General Hospital, Charlestown, MA  UCSF Memory & Aging Center, San Francisco, CA  Indiana University School of Medicine, Indianapolis, IN  Houston Methodist Neurological Institute, Houston, TX